Replies to post #75011 on Biotech Values

[DewDiligence]

MNTA: …it could be your old "regression to the mean argument" in front of an imminent decision. Regardless, I'm not complaining!

Nor am I—MNTA is now up 67% from its low on March 9 (which was also the low for the broad market).